Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of diabetes
3.2.1.2 Advancements in clinical nutrition
3.2.1.3 Growing geriatric population
3.2.2 Industry pitfalls & challenges
3.2.2.1 Limited awareness in developing economies
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Oral nutrition
5.2.1 Not ready-to-use
5.2.2 Ready-to-use
5.2.2.1 Liquids
5.2.2.2 Solids
5.3 Parenteral nutrition
5.3.1 Macronutrients
5.3.1.1 Carbohydrates
5.3.1.2 Amino acids
5.3.1.3 Lipids
5.3.2 Micronutrients
5.3.2.1 Vitamins
5.3.2.2 Minerals
5.4 Enteral feeding formulas
5.4.1 Standard composition
5.4.2 Disease specific composition
Chapter 6 Market Estimates and Forecast, By Disease Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Type 2 diabetes
6.3 Type 1 diabetes
Chapter 7 Market Estimates and Forecast, By Consumer, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Adult
7.3 Pediatric
Chapter 8 Market Estimates and Forecast, By Dosage Form, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Powder
8.3 Liquid
8.4 Solid
Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Retail pharmacies
9.3 Hospital pharmacies
9.4 Online pharmacies
9.5 Other distribution channels
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Abbott Laboratories
11.2 Baxter International Inc.
11.3 B Braun Melsungen AG
11.4 Danone Nutricia
11.5 Dr Reddy's Laboratories Ltd.
11.6 Mead Johnson & Company, LLC
11.7 Nestlé Health Science S.A.
11.8 Nutrego
11.9 Otsuka Holdings Co., Ltd.
11.10 Pfizer Inc.
11.11 Prohance
11.12 Victus, Inc.
